HIMS241227C21500
- 6.50
- 0.000.00%
Hims & Hers Health Newsroom
Hims & Hers Health Options Spot-On: On December 26th, 57,945 Contracts Were Traded, With 457.25K Open Interest
10 Health Care Stocks With Whale Alerts In Today's Session
Unusual Options Activity: MSTR, HIMS and Others Attract Market Bets, MSTR V/OI Ratio Reaches 35.0
Should You Investigate Hims & Hers Health, Inc. (NYSE:HIMS) At US$28.15?
Insider Sale: Chief Commercial Officer of $HIMS (HIMS) Sells 7,500 Shares
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Strong Buy Recommendation for Hims & Hers Health Amid Growth Potential and Market Volatility
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Truist Financial Issues a Hold Rating on Hims & Hers Health (HIMS)
Unusual Options Activity: HIMS, FN and Others Attract Market Bets, HIMS V/OI Ratio Reaches 115.4
Hims & Hers Health: Sell Rating Due to Compounding Exemption Risks and Uncertain GLP-1 Contributions
Sector Update: Health Care Stocks Mixed Premarket Friday
Daily short sale tracking: Micron Technology's short volume increased by 4 million, with a short sale ratio of 11%
Hims & Hers Health Shares Fall on FDA Declaration of End to Tirzepatide Shortage
Top Gap Ups and Downs on Thursday: ACN, MU, VRTX and More
Hims & Hers Health Options Spot-On: On December 19th, 150.18K Contracts Were Traded, With 641.97K Open Interest
Unusual Options Activity: SNAP, WMT and Others Attract Market Bets, SNAP V/OI Ratio Reaches 1136.4
FDA Says Eli Lilly's Zepbound Shortage Over, but Gives Compounders Grace Period
Hims & Hers Health Off 11% On FDA Decision